Quarterly Result6 Feb 2026, 06:12 pm
DCM Nouvelle Ltd Announces Q3 and Nine Months Financial Results for 2025, Recognizes Impairment Provision of ₹ 3,361 Lakhs
AI Summary
DCM Nouvelle Ltd announced the financial results for the quarter and nine months ended December 31, 2025. The Board of Directors approved the un-audited financial results, which were reviewed by the Audit Committee and submitted in accordance with Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company recognized an impairment provision of ₹ 3,361 lakhs on its investment in a subsidiary, DCM Nouvelle Spectralty Chemicals Limited, as the recoverable amount was lower than the carrying amount.
Key Highlights
- DCM Nouvelle Ltd announced Q3 and nine months financial results for 2025.
- The company recognized an impairment provision of ₹ 3,361 lakhs on its investment in a subsidiary.
- The results were reviewed by the Audit Committee and approved by the Board of Directors.
- The financial results were submitted in accordance with Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
- The Board Meeting commenced at 02:00 P.M. and concluded at 05:00 P.M. (IST)
Price Impact
More from DCMNVL